ScienceDex / Researcher record
John Paderi, John Paderi John Paderi
- Ihp Therapeutics, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Top 10% Funded
- Early Career
NIH Funding · FY2023
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2023): $4M in linked award amounts across 3 award records · Award-linked rank #1100.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2023 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2023 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award records by amount
NIH award records listing John Paderi, John Paderi John Paderi as a PI. Multi-PI records show the full award amount for context.
- 1UG3NS134781-01UG3Contact PIA novel glycan-based selectin and complement inhibitor for at-home disease-modifying rescue of pain crisis in sickle cell disease$2.6Maward amount
- 4R44HL167473-02R44Contact PIDevelopment of a novel disease-modifying glycan therapeutic for early at-home intervention of acute vaso-occlusive crisis in sickle cell disease$1.1Maward amount
- 1R44HL167473-01R44Contact PIDevelopment of a novel disease-modifying glycan therapeutic for early at-home intervention of acute vaso-occlusive crisis in sickle cell disease$301.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing John Paderi, John Paderi John Paderi as a PI.
FY2023 award administered by Ihp Therapeutics, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2023First NIH AwardIhp Therapeutics, Inc.
- 2023$500K Cumulative Funding
- 2023$1M Cumulative Funding
- 2023$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #1100
- 2023Entered Top 25% NationallyRanked #1100
- 2023Entered Top 10% NationallyRanked #1100